mortality in India, after heart disorders, with India accounting for 32% of the worldwide COPD burden. According to the Mumbai-based pharmaceutical company, Spirofy is the product of five years of painstaking in-house research, and the innovative gadget employs bacterial virus filters to provide high-accuracy results and individual patient safety.
The Spirofy is completely wireless and has long and strong battery life, making it ideal for usage in outdoor camps, isolated places with power problems, or just affording physicians more flexibility and simplicity of use. The gadget provides real-time reports that may be printed immediately with a small portable wireless thermal printer, or can be sent as a pdf version of the report through phone. Cipla has announced that it will teach clinicians on how to interpret spirometry findings.
